---
title: "Bavarian Nordic – Transactions in Connection with Share Buy-Back Program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289742933.md"
description: "Copenhagen-based Bavarian Nordic A/S (OMX: BAVA) has disclosed its recent activities related to the share buy-back initiative introduced on June 2, 2026. As per the program, the company is set to buy back shares worth a maximum of DKK 150 million between June 2, 2026, and July 10, 2026. This buy-back effort aligns with the guidelines outlined in Regulation (EU) No. 596/2014 (as revised) and Commission Delegated Regulation (EU) 2016/1052, collectively known as the Safe Harbour Regulation."
datetime: "2026-06-15T06:49:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289742933.md)
  - [en](https://longbridge.com/en/news/289742933.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289742933.md)
generator: "portal-rs"
---

# Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Copenhagen-based Bavarian Nordic A/S (OMX: BAVA) has disclosed its recent activities related to the share buy-back initiative introduced on June 2, 2026. As per the program, the company is set to buy back shares worth a maximum of DKK 150 million between June 2, 2026, and July 10, 2026. This buy-back effort aligns with the guidelines outlined in Regulation (EU) No. 596/2014 (as revised) and Commission Delegated Regulation (EU) 2016/1052, collectively known as the Safe Harbour Regulation.

### Related Stocks

- [BVNRY.US](https://longbridge.com/en/quote/BVNRY.US.md)

## Related News & Research

- [Bavarian Nordic CEO Chaplin sells shares worth DKK 19.12 million](https://longbridge.com/en/news/296948284.md)
- [Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance](https://longbridge.com/en/news/296572606.md)
- [BAVA: Upgraded 2026 guidance after strong H1 revenue and profitability, led by Travel Health growth](https://longbridge.com/en/news/296572886.md)
- [Bavarian Nordic Q2 Revenue Up 23%, Upgrades 2026 Guidance; To Initiate Share Buy-back](https://longbridge.com/en/news/296576979.md)
- [Bavarian Nordic says Phase 2 trial supports EU approval of IMVANEX mpox vaccine in children 2-11](https://longbridge.com/en/news/295186449.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**